Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Addict Behav ; 148: 107877, 2024 01.
Artigo em Inglês | MEDLINE | ID: mdl-37804748

RESUMO

INTRODUCTION: People who smoke cigarettes are more likely than people who do not to use cannabis, including blunts, a tobacco product containing nicotine and marijuana. Blunts represent a challenge for cessation trials because nicotine could make stopping cigarettes more difficult. Few studies have examined the impact of blunt use on individuals actively engaged in a cigarette quit attempt. METHODS: Blunt use was assessed at baseline, Weeks 4, 8, 12, 16, and 26 among Black adult people who smoke enrolled in a double-blind, placebo-controlled, randomized trial of varenicline (VAR, n = 300) versus placebo (PBO, n = 200) for smoking cessation. Participants were categorized as ever blunt (blunt use reported at any timepoint) versus non-blunt (no blunt use reported). The primary outcome was salivary cotinine-verified 7-day point prevalence smoking abstinence at Weeks 12 and 26. Logistic regression examined the effects of treatment and blunt use on abstinence. RESULTS: 75 participants (mean age 45.6 years (SD = 12.5, range: 22,80); 32 (42%) female) reported blunt use. Logistic regression analyses showed no treatment by blunt use interaction or significant main effect of blunt use on smoking abstinence at Weeks 12 or 26 (p > 0.05). After adjusting for treatment, those who used blunts had statistically similar odds of quitting at Week 12 (OR: 0.68, 95% CI: 0.31, 1.5) and Week 26 (OR: 0.84, 95% CI: 0.38, 1.87) as those who never used blunts during the study. DISCUSSION: Blunt use had no statistically significant impact on cessation among participants in a smoking cessation clinical trial. Future trials are needed in which the target of cessation is all combustible products.


Assuntos
Negro ou Afro-Americano , Abandono do Hábito de Fumar , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Nicotina , Fumar/etnologia , Abandono do Hábito de Fumar/etnologia , Vareniclina/uso terapêutico
2.
Nicotine Tob Res ; 25(8): 1505-1508, 2023 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-37042345

RESUMO

INTRODUCTION: Alternative nicotine delivery products, including electronic cigarettes (e-cigarettes) and heated tobacco products (HTPs), contain fewer toxicants than combustible cigarettes and offer a potential for harm reduction. Research on the substitutability of e-cigarettes and HTPs is crucial for understanding their impact on public health. This study examined subjective and behavioral preferences for an e-cigarette and HTP relative to participants' usual brand combustible cigarette (UBC) in African American and White smokers naïve to alternative products. AIMS AND METHODS: Twenty-two adult African American (n = 12) and White (n = 10) smokers completed randomized study sessions with their UBC and study provided e-cigarette and HTP. A concurrent choice task allowed participants to earn puffs of the products but placed UBC on a progressive ratio schedule, making puffs harder to earn, and e-cigarette and HTP on a fixed ratio schedule to assess behavioral preference for the products. Behavioral preference was then compared to self-reported subjective preference. RESULTS: Most participants had a subjective preference for UBC (n = 11, 52.4%), followed by an equal preference for e-cigarette (n = 5, 23.8%) and HTP (n = 5, 23.8%). During the concurrent choice task, participants showed a behavioral preference (i.e., more earned puffs) for the e-cigarette (n = 9, 42.9%), followed by HTP (n = 8, 38.1%), and UBC (n = 4, 19.1%). Participants earned significantly more puffs of the alternative products compared to UBC (p = .011) with no difference in earned puffs between e-cigarettes and HTP (p = .806). CONCLUSIONS: In a simulated lab setting, African American and White smokers were willing to substitute UBC for an e-cigarette or HTP when the attainment of UBC became more difficult. TRIAL REGISTRATION: NCT04646668. IMPLICATIONS: Findings suggest that African American and White smokers are willing to substitute their UBC for an alternative nicotine delivery product (e-cigarette or HTP) when the attainment of cigarettes became more difficult in a simulated lab setting. Findings require confirmation among a larger sample under real-world conditions but add to growing evidence suggesting the acceptability of alternative nicotine delivery products among racially diverse smokers. These data are important as policies that limit the availability or appeal of combustible cigarettes are considered or enacted.


Assuntos
Sistemas Eletrônicos de Liberação de Nicotina , Fumantes , Produtos do Tabaco , Adulto , Humanos , Negro ou Afro-Americano , Nicotina , Fumantes/psicologia , Brancos , Comportamento do Consumidor , Comportamento de Escolha
3.
J Pharm Pract ; : 8971900221134648, 2022 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-36263511

RESUMO

Background: Antimicrobial stewardship program implementation at non-teaching community hospitals differs due to staffing and resource disparities. Objective: Demonstrate that an infectious disease (ID) pharmacist faculty with advanced pharmacy practice experience (APPE) students can expand antimicrobial stewardship services at non-teaching community hospitals. Methods: A single-center, retrospective chart review was conducted comparing prospective audit and feedback antimicrobial stewardship interventions by an ID pharmacist faculty with and without APPE students between January 16, 2020 to January 16, 2021. The primary endpoints were intervention rate and the intervention acceptance rate. Secondary endpoints included: the difference in the time from antimicrobial order to intervention and length of stay, as well as comparison of acceptance rates stratified by intervention type or the antimicrobial intervened upon. Results: A total of 739 antimicrobial stewardship interventions were made with an overall acceptance rate of 55.2%. The ID pharmacist faculty with APPE students had a higher number of interventions and intervention rate per working day compared to without students (428 vs 311 and 4.46 vs 2.99, respectively). Conversely, the intervention acceptance rate was lower for the ID pharmacist faculty with APPE students vs without (48.8% vs 64%, P < .001). Both the median time from antimicrobial order to the intervention and length of stay was lower for the ID pharmacist faculty with students vs without (2.50 days [interquartile range (IQR) 1.24 - 4.01] vs 2.99 days [IQR 1.64 - 4.95], P = .003, and 9.20 days [IQR 5.57 - 14.93] vs 11.69 days [IQR 6.89 - 22.31], P < .001, respectively). The acceptance rates by intervention type and the antimicrobial intervened upon were similar between groups. Conclusion: An ID pharmacist faculty with APPE students at a non-teaching community hospital increased the number of stewardship interventions, and was associated with decreased time from antimicrobial order to intervention and length of stay.

4.
Sci Adv ; 8(16): eabj5227, 2022 Apr 22.
Artigo em Inglês | MEDLINE | ID: mdl-35452291

RESUMO

Here, we report that the LynB splice variant of the Src-family kinase Lyn exerts a dominant immunosuppressive function in vivo, whereas the LynA isoform is uniquely required to restrain autoimmunity in female mice. We used CRISPR-Cas9 gene editing to constrain lyn splicing and expression, generating single-isoform LynA knockout (LynAKO) or LynBKO mice. Autoimmune disease in total LynKO mice is characterized by production of antinuclear antibodies, glomerulonephritis, impaired B cell development, and overabundance of activated B cells and proinflammatory myeloid cells. Expression of LynA or LynB alone uncoupled the developmental phenotype from the autoimmune disease: B cell transitional populations were restored, but myeloid cells and differentiated B cells were dysregulated. These changes were isoform-specific, sexually dimorphic, and distinct from the complete LynKO. Despite the apparent differences in disease etiology and penetrance, loss of either LynA or LynB had the potential to induce severe autoimmune disease with parallels to human systemic lupus erythematosus (SLE).

5.
Innov Pharm ; 12(2)2021.
Artigo em Inglês | MEDLINE | ID: mdl-34345509

RESUMO

BACKGROUND/OBJECTIVES: Many people in the United States (US) store medications, both prescription and over-the-counter, in their households. They may store medications in a designated location which could pose some convenience for the ease of use and access. However, most people may not know if their medications are stored properly to maintain stability and sterility. The objective of this study is to assess the medication storage locations in US households and evaluate appropriateness for each reported stored medication based on the published literature and drug information databases. METHODS: 195 US Qualtrics panel members completed the National Household Medication Survey about medications stored at home and the number of residents in the household. This survey was a cross-sectional, self-administered, online survey completed through Qualtrics. The reported medications and their corresponding storage locations were categorized based on their appropriateness with moisture/humidity, temperatures and accidental exposure to children. The number of medications stored appropriately per household was recorded based on published literature, Lexicomp, Nature Made and Nature's Bounty were consulted. RESULTS: 154 (79%) households completed the survey. 75 (38.4%) households had at least one resident younger than 18 years old. 72 (46.8%) households stored at least one medication on a countertop. Only 28 (23.3%) households stored all their medications appropriately, while 92 (76.7%) households were storing at least one medication inappropriately. 34 (22%) households reported medications that were unidentifiable or no medications at all.457 medications were reported by the 154 households. 13 of the households did not store any medications at home. 162-164 (~35%) of the medications were stored appropriately. 52 to 54 (~11%) medications had a moisture/humidity issue, 77 to 79 (~17%) had a temperature issue, and 42 to 44 (~9%) medications had both issues. 23 (5%) medications had an issue with a potential risk for accidental exposure to children, 6 (1.3%) had issues with both risk for accidental exposure to children and moisture/humidity, 8 (1.8%) had issues with both risk for accidental exposure to children and temperature, and 4 (0.9%) medications shared all three issues. Some numbers are reported with a range because certain medications have different storage recommendations based on formulation, so if a formulation wasn't specified, both storage recommendations were taken into consideration. CONCLUSION: The findings suggest that many US households may be storing medications in inappropriate locations. In order to ensure medication stability and sterility and reduce the risk of accidental ingestion, pharmacists should proactively educate patients on proper storage of their medications and signs of degradation to avoid undesirable effects from the medications.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA